Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
- PMID: 33885740
- PMCID: PMC8063132
- DOI: 10.1001/jamapediatrics.2021.1050
Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study
Erratum in
-
Misspelled Author Name in the Byline.JAMA Pediatr. 2022 Jan 1;176(1):104. doi: 10.1001/jamapediatrics.2021.4953. JAMA Pediatr. 2022. PMID: 34779828 Free PMC article. No abstract available.
Abstract
Importance: Detailed information about the association of COVID-19 with outcomes in pregnant individuals compared with not-infected pregnant individuals is much needed.
Objective: To evaluate the risks associated with COVID-19 in pregnancy on maternal and neonatal outcomes compared with not-infected, concomitant pregnant individuals.
Design, setting, and participants: In this cohort study that took place from March to October 2020, involving 43 institutions in 18 countries, 2 unmatched, consecutive, not-infected women were concomitantly enrolled immediately after each infected woman was identified, at any stage of pregnancy or delivery, and at the same level of care to minimize bias. Women and neonates were followed up until hospital discharge.
Exposures: COVID-19 in pregnancy determined by laboratory confirmation of COVID-19 and/or radiological pulmonary findings or 2 or more predefined COVID-19 symptoms.
Main outcomes and measures: The primary outcome measures were indices of (maternal and severe neonatal/perinatal) morbidity and mortality; the individual components of these indices were secondary outcomes. Models for these outcomes were adjusted for country, month entering study, maternal age, and history of morbidity.
Results: A total of 706 pregnant women with COVID-19 diagnosis and 1424 pregnant women without COVID-19 diagnosis were enrolled, all with broadly similar demographic characteristics (mean [SD] age, 30.2 [6.1] years). Overweight early in pregnancy occurred in 323 women (48.6%) with COVID-19 diagnosis and 554 women (40.2%) without. Women with COVID-19 diagnosis were at higher risk for preeclampsia/eclampsia (relative risk [RR], 1.76; 95% CI, 1.27-2.43), severe infections (RR, 3.38; 95% CI, 1.63-7.01), intensive care unit admission (RR, 5.04; 95% CI, 3.13-8.10), maternal mortality (RR, 22.3; 95% CI, 2.88-172), preterm birth (RR, 1.59; 95% CI, 1.30-1.94), medically indicated preterm birth (RR, 1.97; 95% CI, 1.56-2.51), severe neonatal morbidity index (RR, 2.66; 95% CI, 1.69-4.18), and severe perinatal morbidity and mortality index (RR, 2.14; 95% CI, 1.66-2.75). Fever and shortness of breath for any duration was associated with increased risk of severe maternal complications (RR, 2.56; 95% CI, 1.92-3.40) and neonatal complications (RR, 4.97; 95% CI, 2.11-11.69). Asymptomatic women with COVID-19 diagnosis remained at higher risk only for maternal morbidity (RR, 1.24; 95% CI, 1.00-1.54) and preeclampsia (RR, 1.63; 95% CI, 1.01-2.63). Among women who tested positive (98.1% by real-time polymerase chain reaction), 54 (13%) of their neonates tested positive. Cesarean delivery (RR, 2.15; 95% CI, 1.18-3.91) but not breastfeeding (RR, 1.10; 95% CI, 0.66-1.85) was associated with increased risk for neonatal test positivity.
Conclusions and relevance: In this multinational cohort study, COVID-19 in pregnancy was associated with consistent and substantial increases in severe maternal morbidity and mortality and neonatal complications when pregnant women with and without COVID-19 diagnosis were compared. The findings should alert pregnant individuals and clinicians to implement strictly all the recommended COVID-19 preventive measures.
Conflict of interest statement
Figures
![Figure.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/8063132/bin/jamapediatr-e211050-g001.gif)
Comment in
-
COVID-19 in Pregnant Women and Their Newborn Infants.JAMA Pediatr. 2021 Aug 1;175(8):781-783. doi: 10.1001/jamapediatrics.2021.1046. JAMA Pediatr. 2021. PMID: 33885744 No abstract available.
-
Further Observations on Pregnancy Complications and COVID-19 Infection.JAMA Pediatr. 2021 Nov 1;175(11):1185. doi: 10.1001/jamapediatrics.2021.2613. JAMA Pediatr. 2021. PMID: 34398214 No abstract available.
-
Further Observations on Pregnancy Complications and COVID-19 Infection.JAMA Pediatr. 2021 Nov 1;175(11):1184-1185. doi: 10.1001/jamapediatrics.2021.2609. JAMA Pediatr. 2021. PMID: 34398227 Free PMC article. No abstract available.
Similar articles
-
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.Lancet. 2023 Feb 11;401(10375):447-457. doi: 10.1016/S0140-6736(22)02467-9. Epub 2023 Jan 17. Lancet. 2023. PMID: 36669520 Free PMC article.
-
Clinical and epidemiological aspects of SARS-CoV-2 infection among pregnant and postpartum women in Mozambique: a prospective cohort study.Reprod Health. 2022 Jul 19;19(1):164. doi: 10.1186/s12978-022-01469-9. Reprod Health. 2022. PMID: 35854384 Free PMC article.
-
Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study.Am J Obstet Gynecol. 2022 Sep;227(3):488.e1-488.e17. doi: 10.1016/j.ajog.2022.04.019. Epub 2022 Apr 19. Am J Obstet Gynecol. 2022. PMID: 35452653 Free PMC article.
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4. PMID: 28602020 Free PMC article. Updated. Review.
-
Immediate versus deferred delivery of the preterm baby with suspected fetal compromise for improving outcomes.Cochrane Database Syst Rev. 2016 Jul 12;7(7):CD008968. doi: 10.1002/14651858.CD008968.pub3. Cochrane Database Syst Rev. 2016. PMID: 27404120 Free PMC article. Review.
Cited by
-
Successful use of tocilizumab and casirivimab/imdevimab in a twin pregnancy with critical COVID-19 - A case report.Heliyon. 2024 May 22;10(11):e31737. doi: 10.1016/j.heliyon.2024.e31737. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38828309 Free PMC article.
-
Vertical transmission of SARS-CoV-2 delta-variant in a preterm infant.BMC Infect Dis. 2024 May 28;24(1):537. doi: 10.1186/s12879-024-09420-y. BMC Infect Dis. 2024. PMID: 38807052 Free PMC article.
-
Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero.Sci Rep. 2024 May 24;14(1):11851. doi: 10.1038/s41598-024-61918-2. Sci Rep. 2024. PMID: 38789553 Free PMC article.
-
Long COVID in Children, Adults, and Vulnerable Populations: A Comprehensive Overview for an Integrated Approach.Diseases. 2024 May 6;12(5):95. doi: 10.3390/diseases12050095. Diseases. 2024. PMID: 38785750 Free PMC article. Review.
-
Efficient transplacental transfer of SARS-CoV-2 antibodies between naturally exposed mothers and infants in Accra, Ghana.Sci Rep. 2024 May 10;14(1):10772. doi: 10.1038/s41598-024-61496-3. Sci Rep. 2024. PMID: 38730052 Free PMC article.
References
-
- Yap M, Debenham L, Kew T, et al. ; PregCOV-19 Consortium . Clinical manifestations, prevalence, risk factors, outcomes, transmission, diagnosis and treatment of COVID-19 in pregnancy and postpartum: a living systematic review protocol. BMJ Open. 2020;10(12):e041868. doi:10.1136/bmjopen-2020-041868 - DOI - PMC - PubMed
-
- Knight M, Bunch K, Vousden N, et al. ; UK Obstetric Surveillance System SARS-CoV-2 Infection in Pregnancy Collaborative Group . Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020;369:m2107. doi:10.1136/bmj.m2107 - DOI - PMC - PubMed